|
|
Volumn 88, Issue 3, 2001, Pages 301-302
|
|
The management of intractable haematuria [3]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
MACROGOL DERIVATIVE;
POLIDOCANOL;
SCLEROSING AGENT;
MESNA;
PROTECTIVE AGENT;
ACETYLCYSTEINE;
ACROLEIN;
ALUMINUM POTASSIUM SULFATE;
AMIFOSTINE;
CARBOPROST;
CHITOSAN;
CYCLOPHOSPHAMIDE;
FORMALDEHYDE;
MISOPROSTOL;
SILVER NITRATE;
VASOPRESSIN;
VIDARABINE;
BLEEDING;
CHRONIC DISEASE;
CYSTITIS;
HEMATURIA;
HUMAN;
LASER COAGULATION;
METHODOLOGY;
NOTE;
SCLEROTHERAPY;
BONE MARROW TRANSPLANTATION;
BLADDER CARCINOMA;
BLADDER IRRIGATION;
DRUG HALF LIFE;
DRUG INDUCED DISEASE;
ENDOSCOPIC SCLEROTHERAPY;
HEMORRHAGIC CYSTITIS;
INTERMETHOD COMPARISON;
LETTER;
MUCUS SECRETION;
NONHUMAN;
PRIORITY JOURNAL;
PROSTATE CARCINOMA;
SIDE EFFECT;
TELANGIECTASIA;
THROMBOCYTOPENIA;
TREATMENT FAILURE;
TREATMENT OUTCOME;
CHRONIC DISEASE;
CYSTITIS;
HEMATURIA;
HEMORRHAGE;
HUMANS;
LASER COAGULATION;
POLYETHYLENE GLYCOLS;
SCLEROSING SOLUTIONS;
SCLEROTHERAPY;
BONE MARROW TRANSPLANTATION;
MESNA;
PROTECTIVE AGENTS;
|
|
EID: 0034741446
PISSN: 14644096
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1464-410x.2001.2310c.x Document Type: Letter |
|
Times cited : (3)
|
|
References (0)
|